Send your comments and tips to email@example.com
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Dr. Flea's blog
Nurse at small
Your Child's Health Blog
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Thursday, March 22, 2007
Creatine to be studied in new Parkinson's trial
By Carey Goldberg, Globe Staff
Federal researchers announced early today that theyíre launching a nationwide trial to see whether creatine, a supplement long favored by body-builders, can slow the effects of Parkinsonís Disease.
The National Institute of Neurological Disorders and Stroke is aiming to enroll more than 1,700 Parkinsonís patients at sites around the country, including two in Boston: one at Brigham and Womenís Hospital and one at Beth Israel Deaconess Medical Center.
Parkinsonís is a degenerative illness that affects more than a million Americans. Initial studies suggest that creatine may slow the degeneration. Some drugs can help relieve the tremors and other symptoms of Parkinsonís, but none seems able to stop the disease from progressively worsening.
Patients in the clinical trial will be expected to participate for from five to seven years.
More info: 1-800-352-9424; firstname.lastname@example.org.